Cargando…

Autoantigen-Specific B-Cell Depletion Overcomes Failed Immune Tolerance in Type 1 Diabetes

Eliminating autoantigen-specific B cells is an attractive alternative to global B-cell depletion for autoimmune disease treatment. To identify the potential for targeting a key autoimmune B-cell specificity in type 1 diabetes, insulin-binding B cells were tracked within a polyclonal repertoire using...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, Rachel A., Kendall, Peggy L., Thomas, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402296/
https://www.ncbi.nlm.nih.gov/pubmed/22698916
http://dx.doi.org/10.2337/db11-1746